Expecting $19 Million Cash Income FREMONT, CA - March 19, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The business’s 50 day moving average is $0.61 and its 200 day moving average is $0.59. ABVC BioPharma has a 12-month low of $0.40 and a 12-month high of $1.73. The stock has a market cap of $13. ...

FREMONT, CA - April 3, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ophthalmology, CNS (central nervous ...

ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million 03.04.2025 / 15:05 CET/CEST The issuer is solely responsible for the content of this announcement.

JPMorgan sees biopharma as a "safe haven" amid tariff uncertainty, with impacts likely delayed until 2026. Biopharma ETFs like IHE and XPH offer exposure to resilient drugmakers navigating ...

Efforts to battle the 1,250-acre fire in eastern California were complicated by strong winds, which were expected to continue through Monday. By Amanda Holpuch A wildfire in eastern California ...